Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment
Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
Glatiramer acetate (GA), a commonly used treatment for multiple sclerosis (MS), requires long-term frequent injections to ensure its effectiveness. This often leads to adverse effects, patient noncompliance, and economic inefficiency.
Objectives
In this study, poloxamer, as a thermosensitive polymer modified by chitosan (CS) and...
Alternative Titles
Full title
Glatiramer acetate in situ forming gel, a new approach for multiple sclerosis treatment
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_3100275066
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3100275066
Other Identifiers
ISSN
2008-2231,1560-8115
E-ISSN
2008-2231
DOI
10.1007/s40199-024-00532-z